These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19595845)

  • 1. Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor.
    Snyder PJ; Bednar MM; Cromer JR; Maruff P
    Alzheimers Dement; 2005 Oct; 1(2):126-35. PubMed ID: 19595845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults.
    Thomas E; Snyder PJ; Pietrzak RH; Jackson CE; Bednar M; Maruff P
    Neuropsychologia; 2008 Aug; 46(10):2476-84. PubMed ID: 18514746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats.
    de Bruin NM; Prickaerts J; van Loevezijn A; Venhorst J; de Groote L; Houba P; Reneerkens O; Akkerman S; Kruse CG
    Neurobiol Learn Mem; 2011 Sep; 96(2):392-402. PubMed ID: 21757018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive effects of a cholinesterase inhibitor and a histamine inverse agonist on scopolamine deficits in humans.
    Cho W; Maruff P; Connell J; Gargano C; Calder N; Doran S; Fox-Bosetti S; Hassan A; Renger J; Herman G; Lines C; Verma A
    Psychopharmacology (Berl); 2011 Dec; 218(3):513-24. PubMed ID: 21644059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of donepezil on memory and cognition in multiple sclerosis.
    Christodoulou C; Melville P; Scherl WF; Macallister WS; Elkins LE; Krupp LB
    J Neurol Sci; 2006 Jun; 245(1-2):127-36. PubMed ID: 16626752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25-35).
    Tsunekawa H; Noda Y; Mouri A; Yoneda F; Nabeshima T
    Behav Brain Res; 2008 Jul; 190(2):224-32. PubMed ID: 18420288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice.
    Cachard-Chastel M; Devers S; Sicsic S; Langlois M; Lezoualc'h F; Gardier AM; Belzung C
    Behav Brain Res; 2008 Mar; 187(2):455-61. PubMed ID: 18061284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.
    de Bruin NM; Prickaerts J; Lange JH; Akkerman S; Andriambeloson E; de Haan M; Wijnen J; van Drimmelen M; Hissink E; Heijink L; Kruse CG
    Neurobiol Learn Mem; 2010 May; 93(4):522-31. PubMed ID: 20132903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.
    Leroi I; Brandt J; Reich SG; Lyketsos CG; Grill S; Thompson R; Marsh L
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):1-8. PubMed ID: 14716693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge model.
    Baakman AC; Alvarez-Jimenez R; Loewen G; de Kam ML; Broekhuizen K; Hilt DC; Groeneveld GJ
    Alzheimers Dement (N Y); 2019; 5():89-98. PubMed ID: 30984817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the cholinesterase inhibitors donepezil and metrifonate on scopolamine-induced impairments in the spatial cone field orientation task in rats.
    van der Staay FJ; Bouger PC
    Behav Brain Res; 2005 Jan; 156(1):1-10. PubMed ID: 15474645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scopolamine disrupts place navigation in rats and humans: a translational validation of the Hidden Goal Task in the Morris water maze and a real maze for humans.
    Laczó J; Markova H; Lobellova V; Gazova I; Parizkova M; Cerman J; Nekovarova T; Vales K; Klovrzova S; Harrison J; Windisch M; Vlcek K; Svoboda J; Hort J; Stuchlik A
    Psychopharmacology (Berl); 2017 Feb; 234(4):535-547. PubMed ID: 27885411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cholinergic neurotransmission modulation on visual spatial paired associate learning in healthy human adults.
    Harel BT; Pietrzak RH; Snyder PJ; Maruff P
    Psychopharmacology (Berl); 2013 Aug; 228(4):673-83. PubMed ID: 23568575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological test performance in healthy volunteers before and after donepezil administration.
    Beglinger LJ; Gaydos BL; Kareken DA; Tangphao-Daniels O; Siemers ER; Mohs RC
    J Psychopharmacol; 2004 Mar; 18(1):102-8. PubMed ID: 15107192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The scopolamine model as a pharmacodynamic marker in early drug development.
    Lenz RA; Baker JD; Locke C; Rueter LE; Mohler EG; Wesnes K; Abi-Saab W; Saltarelli MD
    Psychopharmacology (Berl); 2012 Mar; 220(1):97-107. PubMed ID: 21901320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study.
    Fagerlund B; Søholm B; Fink-Jensen A; Lublin H; Glenthøj BY
    Clin Neuropharmacol; 2007; 30(1):3-12. PubMed ID: 17272964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of donepezil in healthy young adults underline the fractionation of executive functioning.
    Ginani GE; Tufik S; Bueno OF; Pradella-Hallinan M; Rusted J; Pompéia S
    J Psychopharmacol; 2011 Nov; 25(11):1508-16. PubMed ID: 21262858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of a glycine reuptake inhibitor R231857 on the central nervous system and on scopolamine-induced impairments in cognitive and psychomotor function in healthy subjects.
    Liem-Moolenaar M; Zoethout RW; de Boer P; Schmidt M; de Kam ML; Cohen AF; Franson KL; van Gerven JM
    J Psychopharmacol; 2010 Nov; 24(11):1681-7. PubMed ID: 19648218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.